Pharmacological inhibition of SF3B1 by pladienolide B reduces tumor growth in cervical cancer, hepatocellular cancer, glioblastoma, chronic lymphocytic leukemia, and endometrial cancer [14–18]. The gene discussed is SF3B1; the disease is neoplasm.